Mohammad Alfrad Nobel Bhuiyan, PhD, Assistant Professor and Director of Biostatistics and Computational Biology awarded $219,000 (per year) from NIGMS "Redox, Environmental, and Metabolomics: investigating Disease Yield (REMEDY)."
Faculty, staff and students at LSU Health Shreveport are actively engaged in research in a variety of biomedical areas, with concentrations in cancer, cardiovascular sciences, virology, neuroscience, addiction and immunology. A core part of the institution’s mission, research on campus ranges from basic science to translational research and testing the latest therapies in clinical trials. The School of Graduate Studies helps to train future scientists, and our six centers, four of which are Louisiana Board of Regents recognized Centers of Excellence, further elevate our research portfolio.
The Office of the Vice Chancellor for Research supports these endeavors and is comprised of the Office for Sponsored Programs and Technology Transfer, Research Development and Management, Human Research Protections Program (HRPP), the Institutional Review Board (IRB), and the Research Core Facility.
Research by the NUMBERS
TOTAL Federal Grant Funding (FY21-22)
$18,490,000
↑ 300% increase in grant funding since FY15
Technology Transfer (FY20-21)
Invention Disclosures: 32
Patents Filed: 421 l Patents Issued: 8 U.S. / 1 Foreign
Licenses and Options: 6
Total Licensing Income: $519,000
Ranked 2nd in the LSU System for tech transfer
RECENT RESEARCH AWARDS
Manikandan Panchatcharam, PhD awarded a five-year, $1.6M R01 grant from the NIH's National Institute on Alcohol Abuse and Alcoholism
Xiaohong Lu, PhD, Associate Professor of Pharmacology, Toxicology and Neuroscience, awarded a one-year $506,052 R56 grant from the NIH National Institute of Neurological Disorders and Stroke.
J. Dedrick Jordan, MD, PhD, MSQM, MBA, Professor and Chair of Neurology, was recently awarded a four-year $1,460,000 USAMRAA grant from the Department of Defense for his project, “Photobiomodulation Therapy Could be a Potential Treatment Strategy for Post-Traumatic Stress Disorder."
Md. Shenuarin Bhuiyan, PhD, Associate Professor of Pathology and Translational Pathobiology, was recently awarded a five-year $3,301,470 R01 grant from the NIH National Heart, Lung and Blood Institute for his project, “Novel mitophagy regulatory mechanism in heart failure."
A. Wayne Orr, PhD, Professor and Director of the Research Division for Pathology and Translational Pathobiology, and Center for Cardiovascular Diseases and Sciences Director, received a 5-year $2,87 million R01 grant from the NIH National Heart, Lung, and Blood Institute for his project, "EphA2 regulation of atherosclerotic smooth muscle phenotype."
Matthew Woolard, PhD, Professor of Microbiology and Immunology, is the Principal Investigator awarded a $2.2M 4-year ROI grant by the National Institute of Health.
Hui-Chao (Reggie) Lee, PhD, LSUHS Assistant Professor of Neurology, is the Principal Investigator on a 3-Year Transformational Project Award funded by the American Heart Association for $300,000.
Jeremy Kamil, PhD, Associate Professor of Microbiology and Immunology, is the Principal Investigator awarded a $2M 5-year ROI competing continuation grant by the National Institute of Health.
Hong Sun, MD, PhD, Associate Professor of Cellular Biology and Anatomy, was awarded a $1.8M 5-year R01 competing continuation grant from the NIH National Institute on Alcohol Abuse and Alcoholism.
Krista Rodgers, PhD, was recently awarded an NIH RO1 grant entitled “Mechanisms of Juvenile Neurogenesis and Post-Stroke Recovery: Determining the Role of Age-Associated Neuroimmune Interactions” from the National Institute of Neurological Disorders and Stroke.
Art Yurdagul, PhD, Assistant Professor of Molecular and Cellular Physiology, was awarded a $2.8M 5-year ROI Grant by the National Institutes of Health's National Heart, Lung, and Blood Institute.
Nirav Dhanesha, PhD, Assistant Professor of Pathology and Translational Pathobiology, received a 5-year $2.24 million R01 grant from the NIH’s National Heart, Lung and Blood Institute for his project “Mechanisms for Deep Vein Thrombosis following Stroke.”
Oren Rom, PhD, RD, Assistant Professor of Pathology and Translational Pathobiology, has been awarded a 5-year, $1.6 million R01 grant from the NIH’s National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) for his project, “Lipidated Amino Acids in Cardiometabolic Diseases.”
The Center for Redox Biology and Cardiovascular Disease CoBRE at LSU Health Shreveport, led by Principal Investigator Chris Kevil, PhD, was awarded a $730,000 supplement award from the NIH’s National Institute of General Medical Sciences (NIGMS) for “SARS-CoV-2 Genomic Surveillance in North Louisiana.”
LATEST NEWS HIGHLIGHTS
KTBS 3 - Mall St. Vincent in Shreveport is about to have a new anchor tenant occupying the space vacated by Sears in 2018. Recently, the LSU Health Shreveport Foundation purchased the property for $3.5 million.
The Accreditation Committee of the College of American Pathologists (CAP) has awarded continuing accreditation to the Feist-Weiller Cancer Center’s Center for Precision Medicine Genomics Laboratory at LSUHS.
318 Forum - In response to continued growth in externally funded research over the last several years, LSUHS announced plans to reimagine the former Sears property at Mall St. Vincent as a state-of-the-art research facility focusing on cancer and cardiovascular research.
BRAID 2024 brought scientists and students together to highlight the importance of research in the biomedical industry.
Congratulations to six of our distinguished faculty members who have been recognized in the 2024 Stanford/Elsevier Top 2% Scientists List for their exceptional contributions to scientific research over the past year.
Mohammad Alfrad Nobel Bhuiyan, PhD, Assistant Professor and Director of Biostatistics and Computational Biology awarded $219,000 (per year) from NIGMS "Redox, Environmental, and Metabolomics: investigating Disease Yield (REMEDY)."
Shreveport Times - LSU Health Shreveport is planning to revitalize the local landmark Sears space in Mall St. Vincent and turn it into a state-of-the-art research facility. This will help attract more world-class funded researchers and give them the space they need to thrive.
World Heart Day, Sept. 29, raises awareness about cardiovascular diseases and preventive measure to manage heart disease. LSUHS is honored to have been selected as one of 60 sites in the world to participate in the CORVIA Shunt Clinical Trial for HFpEF patients who have been shown in prior studies to benefit from shunting and have no pulmonary vascular disease or pacemakers.
Congratulations to Molecular and Cellular Physiology faculty, Dr. Arif Yurdagul for making Stanford University's "World's Top 2% Scientists List".